Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean Thierry-Mieg is active.

Publication


Featured researches published by Jean Thierry-Mieg.


Genome Biology | 2006

AceView: a comprehensive cDNA-supported gene and transcripts annotation

Danielle Thierry-Mieg; Jean Thierry-Mieg

BackgroundRegions covering one percent of the genome, selected by ENCODE for extensive analysis, were annotated by the HAVANA/Gencode group with high quality transcripts, thus defining a benchmark. The ENCODE Genome Annotation Assessment Project (EGASP) competition aimed at reproducing Gencode and finding new genes. The organizers evaluated the protein predictions in depth. We present a complementary analysis of the mRNAs, including alternative transcript variants.ResultsWe evaluate 25 gene tracks from the University of California Santa Cruz (UCSC) genome browser. We either distinguish or collapse the alternative splice variants, and compare the genomic coordinates of exons, introns and nucleotides. Whole mRNA models, seen as chains of introns, are sorted to find the best matching pairs, and compared so that each mRNA is used only once. At the mRNA level, AceView is by far the closest to Gencode: the vast majority of transcripts of the two methods, including alternative variants, are identical. At the protein level, however, due to a lack of experimental data, our predictions differ: Gencode annotates proteins in only 41% of the mRNAs whereas AceView does so in virtually all. We describe the driving principles of AceView, and how, by performing hand-supervised automatic annotation, we solve the combinatorial splicing problem and summarize all of GenBank, dbEST and RefSeq into a genome-wide non-redundant but comprehensive cDNA-supported transcriptome. AceView accuracy is now validated by Gencode.ConclusionRelative to a consensus mRNA catalog constructed from all evidence-based annotations, Gencode and AceView have 81% and 84% sensitivity, and 74% and 73% specificity, respectively. This close agreement validates a richer view of the human transcriptome, with three to five times more transcripts than in UCSC Known Genes (sensitivity 28%), RefSeq (sensitivity 21%) or Ensembl (sensitivity 19%).


Nature Genetics | 1992

A survey of expressed genes in Caenorhabditis elegans.

Robert H. Waterston; C. Martin; M. Craxton; C. Huynh; Alan Coulson; LaDeana W. Hillier; Richard Durbin; Philip Green; R. Shownkeen; N. Halloran; Mark M. Metzstein; T. Hawkins; Richard Wilson; M. Berks; Z. Du; K. Thomas; Jean Thierry-Mieg; John E. Sulston

As an adjunct to the genomic sequencing of Caenorhabditis elegans, we have investigated a representative cDNA library of 1,517 clones. A single sequence read has been obtained from the 5′ end of each clone, allowing its characterization with respect to the public databases, and the clones are being localized on the genome map. The result is the identification of about 1,200 of the estimated 15,000 genes of C. elegans. More than 30% of the inferred protein sequences have significant similarity to existing sequences in the databases, providing a route towards in vivo analysis of known genes in the nematode. These clones also provide material for assessing the accuracy of predicted exons and splicing patterns and will lead to a more accurate estimate of the total number of genes in the organism than has hitherto been available.


Nucleic Acids Research | 2001

WormBase: network access to the genome and biology of Caenorhabditis elegans

Lincoln Stein; Paul W. Sternberg; Richard Durbin; Jean Thierry-Mieg; John Spieth

WormBase (http://www.wormbase.org) is a web-based resource for the Caenorhabditis elegans genome and its biology. It builds upon the existing ACeDB database of the C.elegans genome by providing data curation services, a significantly expanded range of subject areas and a user-friendly front end.


Immunity | 2009

Analysis of Interleukin-21-Induced Prdm1 Gene Regulation Reveals Functional Cooperation of STAT3 and IRF4 Transcription Factors

Hyokjoon Kwon; Danielle Thierry-Mieg; Jean Thierry-Mieg; Hyoung-Pyo Kim; Jangsuk Oh; Chainarong Tunyaplin; Sebastian Carotta; Colleen E. Donovan; Matthew L. Goldman; Prafullakumar Tailor; Keiko Ozato; David E. Levy; Stephen L. Nutt; Kathryn Calame; Warren J. Leonard

Interleukin-21 (IL-21) is a pleiotropic cytokine that induces expression of transcription factor BLIMP1 (encoded by Prdm1), which regulates plasma cell differentiation and T cell homeostasis. We identified an IL-21 response element downstream of Prdm1 that binds the transcription factors STAT3 and IRF4, which are required for optimal Prdm1 expression. Genome-wide ChIP-Seq mapping of STAT3- and IRF4-binding sites showed that most regions with IL-21-induced STAT3 binding also bound IRF4 in vivo and furthermore revealed that the noncanonical TTCnnnTAA GAS motif critical in Prdm1 was broadly used for STAT3 binding. Comparing genome-wide expression array data to binding sites revealed that most IL-21-regulated genes were associated with combined STAT3-IRF4 sites rather than pure STAT3 sites. Correspondingly, ChIP-Seq analysis of Irf4(-/-) T cells showed greatly diminished STAT3 binding after IL-21 treatment, and Irf4(-/-) mice showed impaired IL-21-induced Tfh cell differentiation in vivo. These results reveal broad cooperative gene regulation by STAT3 and IRF4.


Nature Biotechnology | 2014

The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance

Charles Wang; Binsheng Gong; Pierre R. Bushel; Jean Thierry-Mieg; Danielle Thierry-Mieg; Joshua Xu; Hong Fang; Huixiao Hong; Jie Shen; Zhenqiang Su; Joe Meehan; Xiaojin Li; Lu Yang; Haiqing Li; Paweł P. Łabaj; David P. Kreil; Dalila B. Megherbi; Stan Gaj; Florian Caiment; Joost H.M. van Delft; Jos Kleinjans; Andreas Scherer; Viswanath Devanarayan; Jian Wang; Yong Yang; Hui-Rong Qian; Lee Lancashire; Marina Bessarabova; Yuri Nikolsky; Cesare Furlanello

The concordance of RNA-sequencing (RNA-seq) with microarrays for genome-wide analysis of differential gene expression has not been rigorously assessed using a range of chemical treatment conditions. Here we use a comprehensive study design to generate Illumina RNA-seq and Affymetrix microarray data from the same liver samples of rats exposed in triplicate to varying degrees of perturbation by 27 chemicals representing multiple modes of action (MOAs). The cross-platform concordance in terms of differentially expressed genes (DEGs) or enriched pathways is linearly correlated with treatment effect size (R20.8). Furthermore, the concordance is also affected by transcript abundance and biological complexity of the MOA. RNA-seq outperforms microarray (93% versus 75%) in DEG verification as assessed by quantitative PCR, with the gain mainly due to its improved accuracy for low-abundance transcripts. Nonetheless, classifiers to predict MOAs perform similarly when developed using data from either platform. Therefore, the endpoint studied and its biological complexity, transcript abundance and the genomic application are important factors in transcriptomic research and for clinical and regulatory decision making.


Nature Biotechnology | 2006

Using RNA sample titrations to assess microarray platform performance and normalization techniques

Richard Shippy; Stephanie Fulmer-Smentek; Roderick V. Jensen; Wendell D. Jones; Paul K. Wolber; Charles D. Johnson; P. Scott Pine; Cecilie Boysen; Xu Guo; Eugene Chudin; Yongming Andrew Sun; James C. Willey; Jean Thierry-Mieg; Danielle Thierry-Mieg; Robert A. Setterquist; Michael Wilson; Natalia Novoradovskaya; Adam Papallo; Yaron Turpaz; Shawn C. Baker; Janet A. Warrington; Leming Shi; Damir Herman

We have assessed the utility of RNA titration samples for evaluating microarray platform performance and the impact of different normalization methods on the results obtained. As part of the MicroArray Quality Control project, we investigated the performance of five commercial microarray platforms using two independent RNA samples and two titration mixtures of these samples. Focusing on 12,091 genes common across all platforms, we determined the ability of each platform to detect the correct titration response across the samples. Global deviations from the response predicted by the titration ratios were observed. These differences could be explained by variations in relative amounts of messenger RNA as a fraction of total RNA between the two independent samples. Overall, both the qualitative and quantitative correspondence across platforms was high. In summary, titration samples may be regarded as a valuable tool, not only for assessing microarray platform performance and different analysis methods, but also for determining some underlying biological features of the samples.


Nature Genetics | 2001

Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans

Jérôme Reboul; Philippe Vaglio; Nia Tzellas; Nicolas Thierry-Mieg; Troy Moore; Cindy Jackson; Tadasu Shin-I; Yuji Kohara; Danielle Thierry-Mieg; Jean Thierry-Mieg; Hongmei Lee; Joseph Hitti; Lynn Doucette-Stamm; James L. Hartley; Gary F. Temple; Michael A. Brasch; Jean Vandenhaute; Philippe Lamesch; David E. Hill; Marc Vidal

The genome sequences of Caenorhabditis elegans, Drosophila melanogaster and Arabidopsis thaliana have been predicted to contain 19,000, 13,600 and 25,500 genes, respectively. Before this information can be fully used for evolutionary and functional studies, several issues need to be addressed. First, the gene number estimates obtained in silico and not yet supported by any experimental data need to be verified. For example, it seems biologically paradoxical that C. elegans would have 50% more genes than Drosophilia. Second, intron/exon predictions need to be tested experimentally. Third, complete sets of open reading frames (ORFs), or “ORFeomes,” need to be cloned into various expression vectors. To address these issues simultaneously, we have designed and applied to C. elegans the following strategy. Predicted ORFs are amplified by PCR from a highly representative cDNA library using ORF-specific primers, cloned by Gateway recombination cloning and then sequenced to generate ORF sequence tags (OSTs) as a way to verify identity and splicing. In a sample (n=1,222) of the nearly 10,000 genes predicted ab initio (that is, for which no expressed sequence tag (EST) is available so far), at least 70% were verified by OSTs. We also observed that 27% of these experimentally confirmed genes have a structure different from that predicted by GeneFinder. We now have experimental evidence that supports the existence of at least 17,300 genes in C. elegans. Hence we suggest that gene counts based primarily on ESTs may underestimate the number of genes in human and in other organisms.


Nature | 2015

Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Martin Peifer; Falk Hertwig; Frederik Roels; Daniel Dreidax; Moritz Gartlgruber; Roopika Menon; Andrea Krämer; Justin L. Roncaioli; Frederik Sand; Johannes M. Heuckmann; Fakhera Ikram; Rene Schmidt; Sandra Ackermann; Anne Engesser; Yvonne Kahlert; Wenzel Vogel; Janine Altmüller; Peter Nürnberg; Jean Thierry-Mieg; Danielle Thierry-Mieg; Aruljothi Mariappan; Stefanie Heynck; Erika Mariotti; Kai-Oliver Henrich; Christian Gloeckner; Graziella Bosco; Ivo Leuschner; Michal R. Schweiger; Larissa Savelyeva; Simon C. Watkins

Neuroblastoma is a malignant paediatric tumour of the sympathetic nervous system. Roughly half of these tumours regress spontaneously or are cured by limited therapy. By contrast, high-risk neuroblastomas have an unfavourable clinical course despite intensive multimodal treatment, and their molecular basis has remained largely elusive. Here we have performed whole-genome sequencing of 56 neuroblastomas (high-risk, n = 39; low-risk, n = 17) and discovered recurrent genomic rearrangements affecting a chromosomal region at 5p15.33 proximal of the telomerase reverse transcriptase gene (TERT). These rearrangements occurred only in high-risk neuroblastomas (12/39, 31%) in a mutually exclusive fashion with MYCN amplifications and ATRX mutations, which are known genetic events in this tumour type. In an extended case series (n = 217), TERT rearrangements defined a subgroup of high-risk tumours with particularly poor outcome. Despite a large structural diversity of these rearrangements, they all induced massive transcriptional upregulation of TERT. In the remaining high-risk tumours, TERT expression was also elevated in MYCN-amplified tumours, whereas alternative lengthening of telomeres was present in neuroblastomas without TERT or MYCN alterations, suggesting that telomere lengthening represents a central mechanism defining this subtype. The 5p15.33 rearrangements juxtapose the TERT coding sequence to strong enhancer elements, resulting in massive chromatin remodelling and DNA methylation of the affected region. Supporting a functional role of TERT, neuroblastoma cell lines bearing rearrangements or amplified MYCN exhibited both upregulated TERT expression and enzymatic telomerase activity. In summary, our findings show that remodelling of the genomic context abrogates transcriptional silencing of TERT in high-risk neuroblastoma and places telomerase activation in the centre of transformation in a large fraction of these tumours.


Nature Communications | 2014

A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages

James C. Fuscoe; Chen Zhao; Chao Guo; Meiwen Jia; Tao Qing; Desmond I. Bannon; Lee Lancashire; Wenjun Bao; Tingting Du; Heng Luo; Zhenqiang Su; Wendell D. Jones; Carrie L. Moland; William S. Branham; Feng Qian; Baitang Ning; Yan Li; Huixiao Hong; Lei Guo; Nan Mei; Tieliu Shi; Kenneth Wang; Russell D. Wolfinger; Yuri Nikolsky; Stephen J. Walker; Penelope Jayne Duerksen-Hughes; Christopher E. Mason; Weida Tong; Jean Thierry-Mieg; Danielle Thierry-Mieg

The rat has been used extensively as a model for evaluating chemical toxicities and for understanding drug mechanisms. However, its transcriptome across multiple organs, or developmental stages, has not yet been reported. Here we show, as part of the SEQC consortium efforts, a comprehensive rat transcriptomic BodyMap created by performing RNA-Seq on 320 samples from 11 organs of both sexes of juvenile, adolescent, adult and aged Fischer 344 rats. We catalogue the expression profiles of 40,064 genes, 65,167 transcripts, 31,909 alternatively spliced transcript variants and 2,367 non-coding genes/non-coding RNAs (ncRNAs) annotated in AceView. We find that organ-enriched, differentially expressed genes reflect the known organ-specific biological activities. A large number of transcripts show organ-specific, age-dependent or sex-specific differential expression patterns. We create a web-based, open-access rat BodyMap database of expression profiles with crosslinks to other widely used databases, anticipating that it will serve as a primary resource for biomedical research using the rat model.


Proceedings of the National Academy of Sciences of the United States of America | 2009

26G endo-siRNAs regulate spermatogenic and zygotic gene expression in Caenorhabditis elegans

Ting Han; Arun Prasad Manoharan; Tim T. Harkins; Pascal Bouffard; Colin Fitzpatrick; Diana S. Chu; Danielle Thierry-Mieg; Jean Thierry-Mieg; John Kim

Endogenous small interfering RNAs (endo-siRNAs) regulate diverse gene expression programs in eukaryotes by either binding and cleaving mRNA targets or mediating heterochromatin formation; however, the mechanisms of endo-siRNA biogenesis, sorting, and target regulation remain poorly understood. Here we report the identification and function of a specific class of germline-generated endo-siRNAs in Caenorhabditis elegans that are 26 nt in length and contain a guanine at the first nucleotide position (i.e., 26G RNAs). 26G RNAs regulate gene expression during spermatogenesis and zygotic development, and their biogenesis requires the ERI-1 exonuclease and the RRF-3 RNA-dependent RNA polymerase (RdRP). Remarkably, we identified two nonoverlapping subclasses of 26G RNAs that sort into specific RNA-induced silencing complexes (RISCs) and differentially regulate distinct mRNA targets. Class I 26G RNAs target genes are expressed during spermatogenesis, whereas class II 26G RNAs are maternally inherited and silence gene expression during zygotic development. These findings implicate a class of endo-siRNAs in the global regulation of transcriptional programs required for fertility and development.

Collaboration


Dive into the Jean Thierry-Mieg's collaboration.

Top Co-Authors

Avatar

Danielle Thierry-Mieg

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Richard Durbin

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Lincoln Stein

Ontario Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Huixiao Hong

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

LaDeana W. Hillier

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Leming Shi

National Center for Toxicological Research

View shared research outputs
Top Co-Authors

Avatar

Zhenqiang Su

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Denis Bernard

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge